{"id":90513,"date":"2023-08-03T10:20:00","date_gmt":"2023-08-03T03:20:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2023080310200090513"},"modified":"2023-08-03T15:24:31","modified_gmt":"2023-08-03T07:24:31","slug":"%e3%80%902023-esmo%e3%80%91%e4%ba%9a%e7%9b%9b%e5%8c%bb%e8%8d%af%e4%b8%a4%e9%a1%b9%e4%b8%b4%e5%ba%8a%e7%a0%94%e7%a9%b6%e5%b0%86%e4%ba%ae%e7%9b%b8%e6%ac%a7%e6%b4%b2%e8%82%bf%e7%98%a4%e5%86%85%e7%a7%91","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2023080310200090513","title":{"rendered":"\u30102023 ESMO\u3011\u4e9a\u76db\u533b\u836f\u4e24\u9879\u4e34\u5e8a\u7814\u7a76\u5c06\u4eae\u76f8\u6b27\u6d32\u80bf\u7624\u5185\u79d1\u5b66\u4f1a\u5e74\u4f1a\uff0c\u5176\u4e2d\u4e00\u9879\u83b7\u53e3\u5934\u62a5\u544a"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/www.xinwengao.com\/cn\/wp-content\/uploads\/Ascentage_Pharma_Logo-26.jpg\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><p><span class=\"legendSpanClass\">\u4e2d\u56fd\u82cf\u5dde\u548c\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u5e02<\/span><span class=\"legendSpanClass\">2023\u5e748\u67083\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u81f4\u529b\u4e8e\u5728\u80bf\u7624\u3001\u4e59\u809d\u53ca\u4e0e\u8870\u8001\u76f8\u5173\u75be\u75c5\u7b49\u6cbb\u7597\u9886\u57df\u5f00\u53d1\u521b\u65b0\u836f\u7269\u7684\u9886\u5148\u751f\u7269\u533b\u836f\u4f01\u4e1a\u2014\u2014\u4e9a\u76db\u533b\u836f\uff086855.HK\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u57282023\u5e74\u6b27\u6d32\u80bf\u7624\u5185\u79d1\u5b66\u4f1a\uff08ESMO\uff09\u5e74\u4f1a\u4e0a\uff0c\u5206\u522b\u4ee5\u5c0f\u578b\u53e3\u5934\u62a5\u544a\uff08mini oral\uff09\u548c\u58c1\u62a5\u7684\u5f62\u5f0f\uff0c\u516c\u5e032\u9879\u4e34\u5e8a\u7814\u7a76\u7ed3\u679c\uff1aBcl-2\/Bcl-xL\u53cc\u9776\u70b9\u6291\u5236\u5242APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u643aEGFR\u7a81\u53d8\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\uff0c\u4ee5\u53ca\u4e2d\u56fd\u9996\u4e2a\u4e14\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684\u7b2c\u4e09\u4ee3BCR-ABL\u6291\u5236\u5242\u5965\u96f7\u5df4\u66ff\u5c3c\uff08HQP1351\uff1b\u5546\u54c1\u540d\uff1a\u8010\u7acb\u514b<sup>&reg;<\/sup>\uff09\u5728\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\u8010\u836f\u7684\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u4e2d\u7684\u4e34\u5e8a\u6570\u636e\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<\/p><\/div>\n<p>ESMO\u5e74\u4f1a\u662f\u5168\u7403\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u80bf\u7624\u5b66\u672f\u4f1a\u8bae\u4e4b\u4e00\uff0c\u4e3a\u5168\u7403\u4e34\u5e8a\u533b\u751f\u3001\u7814\u7a76\u4eba\u5458\u3001\u60a3\u8005\u7b49\u5c55\u793a\u6700\u65b0\u7684\u524d\u6cbf\u6570\u636e\u4e0e\u7814\u7a76\u6210\u679c\u3002\u672c\u5c4aESMO\u5e74\u4f1a\u5c06\u4e8e\u5f53\u5730\u65f6\u95f410\u670820\u65e5\u81f310\u670824\u65e5\u5728\u897f\u73ed\u7259\u9a6c\u5fb7\u91cc\u4e3e\u529e\u3002<\/p>\n<p><b>\u4e9a\u76db\u533b\u836f\u9996\u5e2d\u533b\u5b66\u5b98\u7fdf\u4e00\u5e06\u535a\u58eb<\/b>\u8868\u793a\uff1a&quot;\u5f88\u9ad8\u5174\u770b\u5230APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597NSCLC\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u4e0e\u5965\u96f7\u5df4\u66ff\u5c3c\u6cbb\u7597\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u7684\u7814\u7a76\u8fdb\u5c55\u5165\u90092023 ESMO\u5e74\u4f1a\uff0c\u8fd9\u8fdb\u4e00\u6b65\u4f53\u73b0\u4e86\u516c\u53f8\u7684\u5168\u7403\u521b\u65b0\u4e0e\u4e34\u5e8a\u5f00\u53d1\u5b9e\u529b\uff0c\u4e5f\u518d\u6b21\u5c55\u73b0\u4e86\u4e9a\u76db\u533b\u836f\u5728\u5b9e\u4f53\u7624\u6cbb\u7597\u9886\u57df\u5f3a\u52b2\u7684\u6f5c\u529b\u3002\u6211\u4eec\u5c06\u7ee7\u7eed\u575a\u5b88\u5168\u7403\u521b\u65b0\u7b56\u7565\uff0c\u8fdb\u4e00\u6b65\u63a8\u52a8\u91cd\u70b9\u54c1\u79cd\u5728\u5168\u7403\u5c42\u9762\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u65e9\u65e5\u60e0\u53ca\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u60a3\u8005\u3002&quot;<\/p>\n<p><b>\u4e9a\u76db\u533b\u836f\u5c06\u5728\u672c\u5c4a<\/b><b>ESMO<\/b><b>\u5e74\u4f1a\u5c55\u793a\u7684\u4e24\u9879\u6700\u65b0\u4e34\u5e8a\u8bd5\u9a8c\u8fdb\u5c55\u5305\u62ec\uff1a<\/b><\/p>\n<p><b><u>APG-1252<\/u><\/b><\/p>\n<p>Updated study results of pelcitoclax (APG-1252) combined with osimertinib in patients (pts) with EGFR-mutant non-small cell lung cancer (NSCLC)<br \/>APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u643aEGFR\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u7814\u7a76\u6210\u679c<\/p>\n<ul type=\"disc\">\n<li><b>\u5c55\u793a\u5f62\u5f0f\uff1a<\/b>\u5c0f\u578b\u53e3\u5934\u62a5\u544a<\/li>\n<li><b>\u6458\u8981\u7f16\u53f7\uff1a<\/b>5586<\/li>\n<li><b>\u7c7b\u522b\uff1a<\/b>NSCLC\uff0c\u5c40\u90e8\u665a\u671f\uff08NSCLC, locally advanced\uff09<\/li>\n<li><b>\u7b2c\u4e00\u4f5c\u8005\uff1a<\/b>\u9a6c\u5b87\u7fd4\u535a\u58eb\uff0c\u4e2d\u5c71\u5927\u5b66\u80bf\u7624\u9632\u6cbb\u4e2d\u5fc3<\/li>\n<\/ul>\n<p><b><u>\u5965\u96f7\u5df4\u66ff\u5c3c<\/u><\/b><\/p>\n<p>Antitumor activity of olverembatinib (HQP1351) in patients (pts) with TKI-resistant succinate dehydrogenase- (SDH-) deficient gastrointestinal stromal tumor (GIST)<br \/>\u5965\u96f7\u5df4\u66ff\u5c3c\uff08HQP1351\uff09\u5728\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\u8010\u836f\u7684\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u4e2d\u7684\u6297\u80bf\u7624\u6d3b\u6027<\/p>\n<ul type=\"disc\">\n<li><b>\u5c55\u793a\u5f62\u5f0f\uff1a<\/b>\u58c1\u62a5<\/li>\n<li><b>\u6458\u8981\u7f16\u53f7\uff1a<\/b>5746<\/li>\n<li><b>\u7c7b\u522b\uff1a<\/b>\u8089\u7624\uff08Sarcoma\uff09<\/li>\n<li><b>\u7b2c\u4e00\u4f5c\u8005\uff1a<\/b>\u90b1\u6d77\u6ce2\u535a\u58eb\uff0c\u4e2d\u5c71\u5927\u5b66\u80bf\u7624\u9632\u6cbb\u4e2d\u5fc3<\/li>\n<\/ul>\n<p><i>*<\/i><i>\u8010\u7acb\u514b<\/i><i><sup>&reg;<\/sup><\/i><i>\u5728\u4e2d\u56fd\u7684\u5546\u4e1a\u5316\u63a8\u5e7f\u7531\u4e9a\u76db\u533b\u836f\u4e0e\u4fe1\u8fbe\u751f\u7269\u5236\u836f\uff08<\/i><i>HKEX: 1801<\/i><i>\uff09\u5171\u540c\u8d1f\u8d23\u3002<\/i><\/p>\n<p><b><u>\u5173\u4e8e\u4e9a\u76db\u533b\u836f<\/u><\/b><\/p>\n<p>\u4e9a\u76db\u533b\u836f\u662f\u4e00\u5bb6\u7acb\u8db3\u4e2d\u56fd\u3001\u9762\u5411\u5168\u7403\u7684\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u81f4\u529b\u4e8e\u5728\u80bf\u7624\u3001\u4e59\u809d\u53ca\u4e0e\u8870\u8001\u76f8\u5173\u7684\u75be\u75c5\u7b49\u6cbb\u7597\u9886\u57df\u5f00\u53d1\u521b\u65b0\u836f\u7269\u30022019\u5e7410\u670828\u65e5\uff0c\u4e9a\u76db\u533b\u836f\u5728\u9999\u6e2f\u8054\u4ea4\u6240\u4e3b\u677f\u6302\u724c\u4e0a\u5e02\uff0c\u80a1\u7968\u4ee3\u7801\uff1a6855.HK\u3002<\/p>\n<p>\u4e9a\u76db\u533b\u836f\u62e5\u6709\u81ea\u4e3b\u6784\u5efa\u7684\u86cb\u767d-\u86cb\u767d\u76f8\u4e92\u4f5c\u7528\u9776\u5411\u836f\u7269\u8bbe\u8ba1\u5e73\u53f0\uff0c\u5904\u4e8e\u7ec6\u80de\u51cb\u4ea1\u901a\u8def\u65b0\u836f\u7814\u53d1\u7684\u5168\u7403\u524d\u6cbf\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u62e5\u67099\u4e2a\u5df2\u8fdb\u5165\u4e34\u5e8a\u5f00\u53d1\u9636\u6bb5\u76841\u7c7b\u5c0f\u5206\u5b50\u65b0\u836f\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u5305\u62ec\u6291\u5236Bcl-2\u3001IAP \u6216 MDM2-p53 \u7b49\u7ec6\u80de\u51cb\u4ea1\u901a\u8def\u5173\u952e\u86cb\u767d\u7684\u6291\u5236\u5242\uff1b\u65b0\u4e00\u4ee3\u9488\u5bf9\u764c\u75c7\u6cbb\u7597\u4e2d\u51fa\u73b0\u7684\u6fc0\u9176\u7a81\u53d8\u4f53\u7684\u6291\u5236\u5242\u7b49\uff0c\u4e3a\u5168\u7403\u552f\u4e00\u5728\u7ec6\u80de\u51cb\u4ea1\u901a\u8def\u5173\u952e\u86cb\u767d\u9886\u57df\u5747\u6709\u4e34\u5e8a\u5f00\u53d1\u54c1\u79cd\u7684\u521b\u65b0\u516c\u53f8\u3002\u76ee\u524d\u516c\u53f8\u6b63\u5728\u4e2d\u56fd\u3001\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u53ca\u6b27\u6d32\u5f00\u5c5540\u591a\u9879I\/II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u9ad3\u7ec6\u80de\u767d\u8840\u75c5\u7684\u6838\u5fc3\u54c1\u79cd\u5965\u96f7\u5df4\u66ff\u5c3c\uff08\u5546\u54c1\u540d\uff1a\u8010\u7acb\u514b<sup>&reg;<\/sup>\uff09\u66fe\u83b7\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u65b0\u836f\u5ba1\u8bc4\u4e2d\u5fc3\uff08CDE\uff09\u7eb3\u5165\u4f18\u5148\u5ba1\u8bc4\u548c\u7a81\u7834\u6027\u6cbb\u7597\u54c1\u79cd\uff0c\u5e76\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\uff0c\u662f\u516c\u53f8\u7684\u9996\u4e2a\u4e0a\u5e02\u54c1\u79cd\u3002\u76ee\u524d\uff0c\u8010\u7acb\u514b<sup>&reg;<\/sup>\u5df2\u88ab\u6210\u529f\u7eb3\u5165\u300a\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55(2022\u5e74)\u300b\u3002\u8be5\u54c1\u79cd\u8fd8\u83b7\u5f97\u4e86\u7f8e\u56fdFDA\u5feb\u901f\u901a\u9053\u8d44\u683c\u3001\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u3001\u4ee5\u53ca\u6b27\u76df\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u3002<\/p>\n<p>\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5171\u67094\u4e2a\u5728\u7814\u65b0\u836f\u83b7\u5f9716\u9879FDA\u548c1\u9879\u6b27\u76df\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\uff0c2\u9879FDA\u5feb\u901f\u901a\u9053\u8d44\u683c\u4ee5\u53ca2\u9879FDA\u513f\u7ae5\u7f55\u89c1\u75c5\u8d44\u683c\u8ba4\u8bc1\u3002\u516c\u53f8\u5148\u540e\u627f\u62c5\u591a\u9879\u56fd\u5bb6\u79d1\u6280\u91cd\u5927\u4e13\u9879\uff0c\u5176\u4e2d&quot;\u91cd\u5927\u65b0\u836f\u521b\u5236&quot;\u4e13\u98795\u9879\uff0c\u5305\u62ec1\u9879&quot;\u4f01\u4e1a\u521b\u65b0\u836f\u7269\u5b75\u5316\u57fa\u5730&quot;\u53ca4\u9879&quot;\u521b\u65b0\u836f\u7269\u7814\u53d1&quot;\uff0c\u53e6\u5916\u627f\u62c5&quot;\u91cd\u5927\u4f20\u67d3\u75c5\u9632\u6cbb&quot;\u4e13\u98791\u9879\u3002<\/p>\n<p>\u51ed\u501f\u5f3a\u5927\u7684\u7814\u53d1\u80fd\u529b\uff0c\u4e9a\u76db\u533b\u836f\u5df2\u5728\u5168\u7403\u8303\u56f4\u5185\u8fdb\u884c\u77e5\u8bc6\u4ea7\u6743\u5e03\u5c40\uff0c\u5e76\u4e0eUNITY\u3001MD Anderson\u3001\u6885\u5965\u533b\u5b66\u4e2d\u5fc3\u548cDana-Farber\u764c\u75c7\u7814\u7a76\u6240\u3001\u9ed8\u6c99\u4e1c\u3001\u963f\u65af\u5229\u5eb7\u3001\u8f89\u745e\u7b49\u9886\u5148\u7684\u751f\u7269\u6280\u672f\u53ca\u533b\u836f\u516c\u53f8\u3001\u5b66\u672f\u673a\u6784\u8fbe\u6210\u5168\u7403\u5408\u4f5c\u5173\u7cfb\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u4e00\u652f\u5177\u6709\u4e30\u5bcc\u7684\u539f\u521b\u65b0\u836f\u7814\u53d1\u4e0e\u4e34\u5e8a\u5f00\u53d1\u7ecf\u9a8c\u7684\u56fd\u9645\u5316\u4eba\u624d\u56e2\u961f\uff0c\u540c\u65f6\uff0c\u516c\u53f8\u6b63\u5728\u9ad8\u6807\u51c6\u6253\u9020\u540e\u671f\u7684\u5546\u4e1a\u5316\u751f\u4ea7\u53ca\u5e02\u573a\u8425\u9500\u56e2\u961f\u3002\u4e9a\u76db\u533b\u836f\u5c06\u4e0d\u65ad\u63d0\u9ad8\u7814\u53d1\u80fd\u529b\uff0c\u52a0\u901f\u63a8\u8fdb\u516c\u53f8\u4ea7\u54c1\u7ba1\u7ebf\u7684\u4e34\u5e8a\u5f00\u53d1\u8fdb\u5ea6\uff0c\u771f\u6b63\u8df5\u884c&quot;\u89e3\u51b3\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u60a3\u8005\u5c1a\u672a\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42&quot;\u7684\u4f7f\u547d\uff0c\u4ee5\u9020\u798f\u66f4\u591a\u60a3\u8005\u3002<\/p>\n<p><b><u>\u4e9a\u76db\u533b\u836f\u524d\u77bb\u6027\u58f0\u660e<\/u><\/b><\/p>\n<p>\u672c\u6587\u6240\u4f5c\u51fa\u7684\u524d\u77bb\u6027\u9648\u8ff0\u4ec5\u4e0e\u672c\u6587\u4f5c\u51fa\u8be5\u9648\u8ff0\u5f53\u65e5\u7684\u4e8b\u4ef6\u6216\u8d44\u6599\u6709\u5173\u3002\u9664\u6cd5\u5f8b\u89c4\u5b9a\u5916\uff0c\u4e8e\u4f5c\u51fa\u524d\u77bb\u6027\u9648\u8ff0\u5f53\u65e5\u4e4b\u540e\uff0c\u65e0\u8bba\u662f\u5426\u51fa\u73b0\u65b0\u8d44\u6599\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u5176\u4ed6\u60c5\u51b5\uff0c\u6211\u4eec\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u6216\u516c\u5f00\u4fee\u6539\u4efb\u4f55\u524d\u77bb\u6027\u9648\u8ff0\u53ca\u9884\u6599\u4e4b\u5916\u7684\u4e8b\u4ef6\u3002\u8bf7\u7ec6\u9605\u672c\u6587\uff0c\u5e76\u7406\u89e3\u6211\u4eec\u7684\u5b9e\u9645\u672a\u6765\u4e1a\u7ee9\u6216\u8868\u73b0\u53ef\u80fd\u4e0e\u9884\u671f\u6709\u91cd\u5927\u5dee\u5f02\u3002\u672c\u6587\u5185\u6240\u6709\u9648\u8ff0\u4e43\u672c\u6587\u7ae0\u520a\u53d1\u65e5\u671f\u4f5c\u51fa\uff0c\u53ef\u80fd\u56e0\u672a\u6765\u53d1\u5c55\u800c\u51fa\u73b0\u53d8\u52a8\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">  <\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u4e2d\u56fd\u82cf\u5dde\u548c\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u5e022023\u5e748\u67083\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u81f4\u529b\u4e8e\u5728\u80bf\u7624\u3001\u4e59\u809d\u53ca\u4e0e\u8870\u8001\u76f8\u5173\u75be\u75c5\u7b49\u6cbb\u7597\u9886\u57df\u5f00\u53d1\u521b\u65b0\u836f\u7269\u7684\u9886\u5148\u751f\u7269\u533b\u836f\u4f01\u4e1a\u2014\u2014\u4e9a\u76db\u533b\u836f\uff086855.HK\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u57282023\u5e74\u6b27\u6d32\u80bf\u7624\u5185\u79d1\u5b66\u4f1a\uff08ESMO\uff09\u5e74\u4f1a\u4e0a\uff0c\u5206\u522b\u4ee5\u5c0f\u578b\u53e3\u5934\u62a5\u544a\uff08mini oral\uff09\u548c\u58c1\u62a5\u7684\u5f62\u5f0f\uff0c\u516c\u5e032\u9879\u4e34\u5e8a\u7814\u7a76\u7ed3\u679c\uff1aBcl-2\/Bcl-xL\u53cc\u9776\u70b9\u6291\u5236\u5242APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u643aEGFR\u7a81\u53d8\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\uff0c\u4ee5\u53ca\u4e2d\u56fd\u9996\u4e2a\u4e14\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684\u7b2c\u4e09\u4ee3BCR-ABL\u6291\u5236\u5242\u5965\u96f7\u5df4\u66ff\u5c3c\uff08HQP1351\uff1b\u5546\u54c1\u540d\uff1a\u8010\u7acb\u514b&reg;\uff09\u5728\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\u8010\u836f\u7684\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u4e2d\u7684\u4e34\u5e8a\u6570\u636e\u3002 ESMO\u5e74\u4f1a\u662f\u5168\u7403\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u80bf\u7624\u5b66\u672f\u4f1a\u8bae\u4e4b\u4e00\uff0c\u4e3a\u5168\u7403\u4e34\u5e8a\u533b\u751f\u3001\u7814\u7a76\u4eba\u5458\u3001\u60a3\u8005\u7b49\u5c55\u793a\u6700\u65b0\u7684\u524d\u6cbf\u6570\u636e\u4e0e\u7814\u7a76\u6210\u679c\u3002\u672c\u5c4aESMO\u5e74\u4f1a\u5c06\u4e8e\u5f53\u5730\u65f6\u95f410\u670820\u65e5\u81f310\u670824\u65e5\u5728\u897f\u73ed\u7259\u9a6c\u5fb7\u91cc\u4e3e\u529e\u3002 \u4e9a\u76db\u533b\u836f\u9996\u5e2d\u533b\u5b66\u5b98\u7fdf\u4e00\u5e06\u535a\u58eb\u8868\u793a\uff1a&quot;\u5f88\u9ad8\u5174\u770b\u5230APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597NSCLC\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u4e0e\u5965\u96f7\u5df4\u66ff\u5c3c\u6cbb\u7597\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u7684\u7814\u7a76\u8fdb\u5c55\u5165\u90092023 ESMO\u5e74\u4f1a\uff0c\u8fd9\u8fdb\u4e00\u6b65\u4f53\u73b0\u4e86\u516c\u53f8\u7684\u5168\u7403\u521b\u65b0\u4e0e\u4e34\u5e8a\u5f00\u53d1\u5b9e\u529b\uff0c\u4e5f\u518d\u6b21\u5c55\u73b0\u4e86\u4e9a\u76db\u533b\u836f\u5728\u5b9e\u4f53\u7624\u6cbb\u7597\u9886\u57df\u5f3a\u52b2\u7684\u6f5c\u529b\u3002\u6211\u4eec\u5c06\u7ee7\u7eed\u575a\u5b88\u5168\u7403\u521b\u65b0\u7b56\u7565\uff0c\u8fdb\u4e00\u6b65\u63a8\u52a8\u91cd\u70b9\u54c1\u79cd\u5728\u5168\u7403\u5c42\u9762\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u65e9\u65e5\u60e0\u53ca\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u60a3\u8005\u3002&quot; \u4e9a\u76db\u533b\u836f\u5c06\u5728\u672c\u5c4aESMO\u5e74\u4f1a\u5c55\u793a\u7684\u4e24\u9879\u6700\u65b0\u4e34\u5e8a\u8bd5\u9a8c\u8fdb\u5c55\u5305\u62ec\uff1a APG-1252 Updated study results of pelcitoclax (APG-1252) combined with osimertinib in patients (pts) with EGFR-mutant non-small cell lung cancer (NSCLC)APG-1252\u8054\u5408\u5965\u5e0c\u66ff\u5c3c\u6cbb\u7597\u643aEGFR\u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u7684\u6700\u65b0\u4e34\u5e8a\u7814\u7a76\u6210\u679c \u5c55\u793a\u5f62\u5f0f\uff1a\u5c0f\u578b\u53e3\u5934\u62a5\u544a \u6458\u8981\u7f16\u53f7\uff1a5586 \u7c7b\u522b\uff1aNSCLC\uff0c\u5c40\u90e8\u665a\u671f\uff08NSCLC, locally advanced\uff09 \u7b2c\u4e00\u4f5c\u8005\uff1a\u9a6c\u5b87\u7fd4\u535a\u58eb\uff0c\u4e2d\u5c71\u5927\u5b66\u80bf\u7624\u9632\u6cbb\u4e2d\u5fc3 \u5965\u96f7\u5df4\u66ff\u5c3c Antitumor activity of olverembatinib (HQP1351) in patients (pts) with TKI-resistant succinate dehydrogenase- (SDH-) deficient gastrointestinal stromal tumor (GIST)\u5965\u96f7\u5df4\u66ff\u5c3c\uff08HQP1351\uff09\u5728\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\u8010\u836f\u7684\u7425\u73c0\u9178\u8131\u6c22\u9176\u7f3a\u9677\u578b\uff08SDH-\uff09\u80c3\u80a0\u9053\u95f4\u8d28\u7624\uff08GIST\uff09\u60a3\u8005\u4e2d\u7684\u6297\u80bf\u7624\u6d3b\u6027 \u5c55\u793a\u5f62\u5f0f\uff1a\u58c1\u62a5&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2023080310200090513\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":90516,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-90513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/90513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=90513"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/90513\/revisions"}],"predecessor-version":[{"id":90515,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/90513\/revisions\/90515"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/90516"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=90513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=90513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=90513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}